A number of in vitro/in vivo studies have tested the effects of antiandrogens and/or androgen deprivation in pancreatic cancer models, and have, for the most part, shown that inhibiting AR-signaling exerts anti-tumor effect [106,107,108,109,110,111,112,113]. Here, AR is linked to neoplasm.